As of 2025-07-01, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is (0.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.09 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -108.9%.
The range of the Relative Valuation is (0.74) - (0.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 20.2x | 14.1x |
| Forward P/E multiples | 17.8x - 21.4x | 20.4x |
| Fair Price | (0.74) - (0.84) | (0.72) |
| Upside | -109.1% - -110.4% | -108.9% |
| Date | P/E |
| 2025-06-26 | -195.29 |
| 2025-06-25 | -193.37 |
| 2025-06-24 | -195.29 |
| 2025-06-23 | -190.12 |
| 2025-06-20 | -187.84 |
| 2025-06-18 | -190.72 |
| 2025-06-17 | -189.76 |
| 2025-06-16 | -194.81 |
| 2025-06-13 | -186.16 |
| 2025-06-12 | -191.20 |
| 2025-06-11 | -186.88 |
| 2025-06-10 | -187.60 |
| 2025-06-09 | -182.80 |
| 2025-06-06 | -183.04 |
| 2025-06-05 | -172.23 |
| 2025-06-04 | -173.19 |
| 2025-06-03 | -178.95 |
| 2025-06-02 | -178.23 |
| 2025-05-30 | -175.83 |
| 2025-05-29 | -175.35 |
| 2025-05-28 | -173.19 |
| 2025-05-27 | -175.11 |
| 2025-05-23 | -171.99 |
| 2025-05-22 | -172.71 |
| 2025-05-21 | -174.63 |
| 2025-05-20 | -178.23 |
| 2025-05-19 | -180.15 |
| 2025-05-16 | -182.56 |
| 2025-05-15 | -180.15 |
| 2025-05-14 | -176.55 |
| 2025-05-13 | -180.15 |
| 2025-05-12 | -182.56 |
| 2025-05-09 | -177.99 |
| 2025-05-08 | -179.19 |
| 2025-05-07 | -173.43 |
| 2025-05-06 | -172.47 |
| 2025-05-05 | -181.11 |
| 2025-05-02 | -191.44 |
| 2025-05-01 | -185.92 |
| 2025-04-30 | -184.00 |
| 2025-04-29 | -186.16 |
| 2025-04-28 | -183.04 |
| 2025-04-25 | -179.67 |
| 2025-04-24 | -178.23 |
| 2025-04-23 | -175.35 |
| 2025-04-22 | -174.15 |
| 2025-04-21 | -171.27 |
| 2025-04-17 | -176.79 |
| 2025-04-16 | -172.47 |
| 2025-04-15 | -172.23 |